Analgesics in Turkey
Euromonitor International's Analgesics in Turkey market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 34 | Publication date: Apr 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Systemic analgesics; Topical analgesics/anaesthetic
Table of contents
OTC HEALTHCARE IN TURKEY : MARKET INSIGHT
EXECUTIVE SUMMARY
State Endeavours to Strengthen Competitive Power of Generics
Legislative Changes Slow Introduction of OTC Healthcare Concept
Novartis Leads, Followed by Sandoz
Pharmacies the Dominant Retail Channel
Social Security and General Health Insurance Law Will Lead to Constant Value Decline Over Forecast Period
KEY TRENDS AND DEVELOPMENTS
New National Health System Triggers Volume Growth but Constant Unit Prices Decline
Private Health Insurances Have Positive Impact
Original Patent Time Limits Start to Expire, Number of Generics Increases
Increased Number of Pharmacies Could Not Resolve the Distribution Issue Yet
OTC Regulations Likely to Be Enacted by 2010
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Advertising
Packaging and Labelling
Distribution
De-listing or De-reimbursement
Traditional Remedies
Homeopathy
Consumer Expenditure on Health Goods and Medical Services
Self-medication and Preventative Medicine
Generics
Switches
DEFINITIONS
Summary 1 Research Sources
LOCAL COMPANY PROFILES - TURKEY
ABDI IBRAHIM ILAç SANAYI VE TICARET AS - OTC HEALTHCARE - TURKEY
STRATEGIC DIRECTION
KEY FACTS
Summary 2 Abdi Ibrahim Ilac Sanayi AS: Key Facts
Summary 3 Abdi Ibrahim Ilac Sanayi AS: Operational Indicators 2005-2007
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 4 Abdi Ibrahim Ilac Sanayi AS: Competitive Position 2008
BILIM ILAC SANAYI VE TICARET AS - OTC HEALTHCARE - TURKEY
STRATEGIC DIRECTION
KEY FACTS
Summary 5 Bilim Ilac Sanayi ve Ticaret AS: Key Facts
Summary 6 Bilim Ilac Sanayi ve Ticaret AS: Operational Indicators 2005-2007
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 7 Bilim Ilac Sanayi ve Ticaret AS: Competitive Position 2008
DEVA HOLDING AS - OTC HEALTHCARE - TURKEY
STRATEGIC DIRECTION
KEY FACTS
Summary 8 Deva Holding AS: Key Facts
Summary 9 Deva Holding AS: Operational Indicators 2005-2007
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 10 Deva Holding AS: Competitive Position 2008
ECZACIBASI ILAC SANAYI VE TICARET AS - OTC HEALTHCARE - TURKEY
STRATEGIC DIRECTION
KEY FACTS
Summary 11 Eczacibasi Ilac Sanayi ve Ticaret AS: Key Facts
Summary 12 Eczacibasi Ilac Sanayi ve Ticaret AS: Operational Indicators 2005-2007
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 13 Eczacibasi Ilac Sanayi ve Ticaret AS: Competitive Position 2008
NOBEL ILAC SANAYI VE TICARET AS - OTC HEALTHCARE - TURKEY
STRATEGIC DIRECTION
KEY FACTS
Summary 14 Nobel Ilac Sanayi ve Ticaret AS: Key Facts
Summary 15 Nobel Ilac Sanayi ve Ticaret AS: Operational Indicators 2005-2007
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 16 Nobel Ilac Sanayi ve Ticaret AS: Competitive Position 2008
ANALGESICS IN TURKEY
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 11 Sales of Analgesics by Subsector: Value 2003-2008
Table 12 Sales of Analgesics by Subsector: % Value Growth 2003-2008
Table 13 Herbal vs Standard Topical Analgesics 2003-2008
Table 14 Topical Analgesics by Format: % Value Breakdown 2004-2008
Table 15 Analgesics Company Shares by Value 2004-2008
Table 16 Analgesics Brand Shares by Value 2005-2008
Table 17 Forecast Sales of Analgesics by Subsector: Value 2008-2013
Table 18 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013